Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin versus placebo in septic shock
IRCT20120215009014N296Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in septic shock comparing Routine treatment plus melatonin with Routine treatment plus placebo (2 arms). Primary endpoints: Catalase activity, Superoxide dismutase activity and 6 more. Started Sep 2019; status: completed.
02
Drugs
melatonin
03
Conditions
septic shock
Beyond the preview
Go deeper on IRCT20120215009014N296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N296.